Visit WTR Logo
Subscribe now

United Kingdom

Alibaba deploys tool to provide price guidance for patents going under the hammer

Intangio, developed by valuation specialists Inngot and IP services firm Rouse, is helping insolvency practitioners set a data-driven reserve price for patent assets at bankruptcy auctions

Alibaba deploys tool to provide price guidance for patents going under the hammer
IAM parent company acquires market-leading US patent litigation data and analytics firm
25 Aug 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other practice areas - becomes a Law Business Research company

Chinese court enforces trade secret arbitration award of over $100 million against Chinese company
12 Aug 2021

Chinese court enforces trade secret arbitration award of over $100 million against Chinese company

Dow and Johnson Matthey welcome enforcement action, which comes on the heels of a civil trade secrets litigation win in a different Chinese court last year

Latest

View all
9 Sep 2021

Private practice leadership roundtable

Read more

9 Sep 2021

Life science leaders

Read more

3 Aug 2021

Pfizer gets boost in landmark $1 billion pregabalin patent damages dispute

UK court sides with the drug company on key counterfactual assumptions in high-stakes compensation battle with the NHS and generics Read more

3 Aug 2021

UK to look at whether change to the current SEP framework is required

Moved confirmed in press release issued by the country’s IP office last week with process scheduled to begin in the autumn Read more

Designs

View all
5 Oct 2020

Arm’s patents will help Nvidia in many of the world’s high-growth industries

The proposed tie-up would significantly improve the US company’s IP cover in a number of key areas – but would not come consequence free Read more

10 Aug 2019

A No Deal Brexit now looks unavoidable, so plan accordingly

Boris Johnson becoming Prime Minister has totally changed the trajectory of the UK's departure from the EU and IP owners' strategies should reflect that Read more

3 Jul 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market Read more

3 Jun 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda Read more

Finance

View all
29 Jun 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

6 May 2020

UK parliament committee warned on China’s plans for Imagination Technologies

Imagination owner explains that licensing IP is not the same as transferring it, but freshly resigned CEO claims that only diligent management oversight can prevent key trade secret loss Read more

15 Apr 2020

Looking for IP value in a time of economic shock

Patents, know-how and data, as well as other intellectual assets, are all very interesting opportunities right now - if you know what you are doing Read more

Frand/SEPS

View all
19 Jul 2021

Apple's threat to leave UK market over SEP dispute should not be dismissed as a bluff

In FRAND dust-up with Optis, the iPhone maker has raised the stakes and that could end with the British government getting involved Read more

8 Jul 2021

Nokia launches patent litigation against Oppo across Europe and Asia

The two companies have been re-negotiating a 2018 licensing deal covering wireless technologies Read more

30 Jun 2021

Sisvel, Xiaomi reach settlement over cellular patents

Deal ends litigation in China and Europe, with Xiaomi gaining rights to mobile patents owned by Sisvel and Mitsubishi Electric Read more

11 May 2021

Wireless back to the fore for IP Bridge in multi-jurisdiction patent tangle with Huawei

Japanese fund’s first acquisition and first new litigation since going private have both centred on SEPs Read more

Law & Policy

View all
24 Jul 2021

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes Read more

22 Jul 2021

Australian pharma patentees must remain vigilant on third-party damages

Recent decisions have calmed concerns about a surge of lawsuits against patentees by third parties, but a significant risk remains Read more

8 Jul 2021

New SPC data demonstrates the commercial power of patent extension rights in Europe

A recent report into supplementary protection certificates provides crucial insights for IP strategists and policy-makers Read more

7 Jul 2021

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant

Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement Read more

Litigation

View all
24 Jul 2021

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes Read more

22 Jul 2021

Australian pharma patentees must remain vigilant on third-party damages

Recent decisions have calmed concerns about a surge of lawsuits against patentees by third parties, but a significant risk remains Read more

19 Jul 2021

Apple's threat to leave UK market over SEP dispute should not be dismissed as a bluff

In FRAND dust-up with Optis, the iPhone maker has raised the stakes and that could end with the British government getting involved Read more

8 Jul 2021

Nokia launches patent litigation against Oppo across Europe and Asia

The two companies have been re-negotiating a 2018 licensing deal covering wireless technologies Read more

Market Developments

View all
24 Jul 2021

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes Read more

17 Dec 2020

What you need to know about post-Brexit changes to the UK’s SPC system

Failures to update IP management following the New Year could be costly for life sciences businesses Read more

4 Dec 2020

Chinese court to set global FRAND rate in Oppo-Sharp dispute

Oppo’s major win at the Shenzhen Intermediate People’s Court signifies that China is ready to have a bigger say on global SEP disputes Read more

27 Nov 2020

Do not expect an electronic vehicle patent boom in the UK despite 2030’s petrol and diesel car sales ban

Plans announced by British Prime Minister Boris Johnson will not change the IP reality, which is that Germany is the only serious game in town for auto in Europe Read more

Non-Practising Entities

View all
19 Jul 2021

Apple's threat to leave UK market over SEP dispute should not be dismissed as a bluff

In FRAND dust-up with Optis, the iPhone maker has raised the stakes and that could end with the British government getting involved Read more

11 May 2021

Wireless back to the fore for IP Bridge in multi-jurisdiction patent tangle with Huawei

Japanese fund’s first acquisition and first new litigation since going private have both centred on SEPs Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

15 Feb 2021

Open Invention Network adds major banks to membership with Barclays and TD Bank sign-ups

Risk from rivals, threats from patent assertion entities and the widespread adoption of open source software is increasing financial institutions’ interest in defensive networks, says OIN CEO Read more

Patent Pools

View all
20 Jul 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences Read more

4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

16 Dec 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts Read more

30 Aug 2019

IP market news highlights

Some of the major news stories carried on the IAM platform in June and July Read more

Patents Law

View all
24 Jul 2021

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes Read more

22 Jul 2021

Australian pharma patentees must remain vigilant on third-party damages

Recent decisions have calmed concerns about a surge of lawsuits against patentees by third parties, but a significant risk remains Read more

19 Jul 2021

Apple's threat to leave UK market over SEP dispute should not be dismissed as a bluff

In FRAND dust-up with Optis, the iPhone maker has raised the stakes and that could end with the British government getting involved Read more

8 Jul 2021

New SPC data demonstrates the commercial power of patent extension rights in Europe

A recent report into supplementary protection certificates provides crucial insights for IP strategists and policy-makers Read more

Strategy

View all
8 Jul 2021

New SPC data demonstrates the commercial power of patent extension rights in Europe

A recent report into supplementary protection certificates provides crucial insights for IP strategists and policy-makers Read more

7 Jul 2021

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant

Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement Read more

3 May 2021

New report lays bare the worrying extent of the UK's IP malaise

British companies lag their competitors on a number of measures, as well as on business investment in R&D, according to research published today Read more

23 Feb 2021

How hub-and-spoke businesses are creating new pharma IP monetisation models

The launch of Centessa is the latest development in a trend that has big implications for the monetisation of unpartnered or deprioritised IP-backed pharma assets Read more

Technology Licensing

View all
19 Jul 2021

Apple's threat to leave UK market over SEP dispute should not be dismissed as a bluff

In FRAND dust-up with Optis, the iPhone maker has raised the stakes and that could end with the British government getting involved Read more

8 Jul 2021

Nokia launches patent litigation against Oppo across Europe and Asia

The two companies have been re-negotiating a 2018 licensing deal covering wireless technologies Read more

30 Jun 2021

Sisvel, Xiaomi reach settlement over cellular patents

Deal ends litigation in China and Europe, with Xiaomi gaining rights to mobile patents owned by Sisvel and Mitsubishi Electric Read more

29 Jun 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP Read more

Trade Secrets

View all
3 May 2021

New report lays bare the worrying extent of the UK's IP malaise

British companies lag their competitors on a number of measures, as well as on business investment in R&D, according to research published today Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

21 Aug 2020

Countries that seek to lead in AI must think seriously about how to use IP to protect what it creates

Exclusive article for IAM written by Professor Ryan Abbott, one of the team behind the groundbreaking DABUS patent applications Read more

17 Aug 2020

US company secures injunction against Chinese rival in UK trade secrets case

Dispute between an American plaintiff and a Shenzhen-based defendant, involving alleged theft of IP in China, sees London court making preliminary grant Read more

Valuation

View all
29 Jun 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP Read more

19 Apr 2021

European Super League could face domain and trademark issues as backlash to football revolution grows

Analysis by the team at IAM's sister publication World Trademark Review finds the 12 clubs involved are IP-savvy, but vulnerable to brand risk Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

9 Feb 2021

Five IP takeaways from Jazz Pharmaceuticals’ $7 billion medical cannabis buyout

A major milestone in the medical cannabinoid patent market has been passed Read more

Trending

1

IAM parent company acquires market-leading US patent litigation data and analytics firm

2

The new UK innovation tsar will need to drill deep to tackle the country’s patent lag

3

Revealed: the countries leading the race for blockchain patents

4

It’s a great time to be involved in IP finance

5

Measuring up measurement methods – how to understand EPO patent parameters